Business Description
Bionomics Ltd
SIC : 2836
ISIN : AU000000BNO5
Compare
Compare
Traded in other countries / regions
BNOX.USAB1N0.GermanyBNO.Australia IPO Date
1999-12-21Description
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.18 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Beneish M-Score | -6.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -97.2 | |||||
| 3-Year FCF Growth Rate | -31.7 | |||||
| 3-Year Book Growth Rate | 8.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.33 | |||||
| 9-Day RSI | 41.17 | |||||
| 14-Day RSI | 40.98 | |||||
| 6-1 Month Momentum % | -55.17 | |||||
| 12-1 Month Momentum % | -74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.87 | |||||
| Quick Ratio | 4.87 | |||||
| Cash Ratio | 4.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.9 | |||||
| Shareholder Yield % | -49.44 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -95918.18 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.43 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | 0.48 | |||||
| EV-to-Forward-EBIT | -0.09 | |||||
| EV-to-EBITDA | 0.5 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-Revenue | -699.82 | |||||
| EV-to-Forward-Revenue | 0.51 | |||||
| EV-to-FCF | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
| Price-to-Net-Cash | 1 | |||||
| Earnings Yield (Greenblatt) % | 208.33 | |||||
| FCF Yield % | -143.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionomics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.022 | ||
| EPS (TTM) (A$) | -0.019 | ||
| Beta | 0 | ||
| Volatility % | 55.46 | ||
| 14-Day RSI | 40.98 | ||
| 14-Day ATR (A$) | 0.001541 | ||
| 20-Day SMA (A$) | 0.010975 | ||
| 12-1 Month Momentum % | -74 | ||
| 52-Week Range (A$) | 0.009 - 0.074 | ||
| Shares Outstanding (Mil) | 1,468.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionomics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionomics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bionomics Ltd Frequently Asked Questions
What is Bionomics Ltd(ASX:BNO)'s stock price today?
The current price of ASX:BNO is A$0.01. The 52 week high of ASX:BNO is A$0.07 and 52 week low is A$0.01.
When is next earnings date of Bionomics Ltd(ASX:BNO)?
The next earnings date of Bionomics Ltd(ASX:BNO) is 2024-04-28 Est..
Does Bionomics Ltd(ASX:BNO) pay dividends? If so, how much?
Bionomics Ltd(ASX:BNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers